Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.

Saved in:
Bibliographic Details
Title: Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
Authors: Nul D; GESICA, Av Rivadavia 2358, PB 4 (1034) Buenos Aires, CP 1414, Argentina. gesica@advancedsl.com.ar, Zambrano C, Diaz A, Ferrante D, Varini S, Soifer S, Grancelli H, Doval H
Corporate Authors: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina
Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2005 Mar; Vol. 19 (2), pp. 125-34.
Publication Type: Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print Cited Medium: Print ISSN: 0920-3206 (Print) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0920-3206
DOI:10.1007/s10557-005-1497-5